ITGAM and neoplasm: We found that CD11b+Ly6G+PMN-MDSCs were the major CD11b+Gr-1+ cells subset in the tumor tissue which were significantly decreased in the tumor after GFI treatment in a dose-dependent manner (Fig. 3C, 3D).